We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
ADT
ADT
$5.5B
| $635K | ﹤0.01% |
104,863
-291,963
| -74% | -$2.03M |
|
1602
APi Group
APG
$18.6B
| $634K | ﹤0.01% |
63,575
-26,968
| -30% | -$318K |
|
1603
Tanger
SKT
$4.46B
| $633K | ﹤0.01% |
44,515
-1,764
| -4% | -$29.3K |
|
|
SUM
1604
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $632K | ﹤0.01% |
27,591
-16,732
| -38% | -$444K |
|
|
SFIX
1605
Stitch Fix
SFIX
$503M
| $630K | ﹤0.01% |
127,503
+9,808
| +8% | +$82K |
|
|
PFC
1606
DELISTED
Premier Financial Corp. Common Stock
PFC
| $630K | ﹤0.01% |
24,846
-4,118
| -14% | -$111K |
|
1607
Accuray
ARAY
$35M
| $625K | ﹤0.01% |
318,660
-34,588
| -10% | -$86.4K |
|
|
BHR
1608
Braemar Hotels & Resorts
BHR
$139M
| $623K | ﹤0.01% |
145,260
+34,455
| +31% | +$195K |
|
1609
MasterCraft Boat Holdings
MCFT
$583M
| $619K | ﹤0.01% |
29,403
+8,952
| +44% | +$208K |
|
1610
Casella Waste Systems
CWST
$5.84B
| $616K | ﹤0.01% |
8,475
-2,301
| -21% | -$175K |
|
1611
Columbia Banking Systems
COLB
$8.95B
| $615K | ﹤0.01% |
21,457
-4,195
| -16% | -$124K |
|
1612
Neogen
NEOG
$2.48B
| $611K | ﹤0.01% |
25,566
-5,961
| -19% | -$160K |
|
1613
Stepan Co
SCL
$1.48B
| $609K | ﹤0.01% |
6,009
-2,052
| -25% | -$212K |
|
|
AERI
1614
DELISTED
Aerie Pharmaceuticals
AERI
| $608K | ﹤0.01% |
81,013
+41,813
| +107% | +$295K |
|
1615
Sabesp
SBS
$17.8B
| $607K | ﹤0.01% |
391,736
-496,155
| -56% | -$894K |
|
1616
Green Dot
GDOT
$751M
| $604K | ﹤0.01% |
24,069
-7,319
| -23% | -$198K |
|
|
AMWD
1617
DELISTED
American Woodmark
AMWD
| $603K | ﹤0.01% |
13,387
-1,568
| -10% | -$75.8K |
|
1618
Tactile Systems Technology
TCMD
$548M
| $602K | ﹤0.01% |
82,465
+52,334
| +174% | +$663K |
|
1619
Zillow
Z
$7.7B
| $602K | ﹤0.01% |
19,255
+4,094
| +27% | +$164K |
|
1620
Sprout Social
SPT
$616M
| $599K | ﹤0.01% |
10,321
-8,504
| -45% | -$494K |
|
1621
The ONE Group
STKS
$57.8M
| $599K | ﹤0.01% |
81,259
-33,303
| -29% | -$304K |
|
|
CERE
1622
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $599K | ﹤0.01% |
22,653
+13,363
| +144% | +$379K |
|
1623
Travere Therapeutics
TVTX
$5.8B
| $598K | ﹤0.01% |
24,670
-38,753
| -61% | -$975K |
|
|
ODP
1624
DELISTED
ODP
ODP
| $597K | ﹤0.01% |
19,742
+829
| +4% | +$33.5K |
|
|
LBAI
1625
DELISTED
Lakeland Bancorp Inc
LBAI
| $596K | ﹤0.01% |
40,778
+27,889
| +216% | +$428K |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.